Literature DB >> 7636906

CD11b blockade prevents lung injury despite neutrophil priming after gut ischemia/reperfusion.

K Koike1, E E Moore, F A Moore, R J Franciose, B Fontes, F J Kim.   

Abstract

Gut ischemia/reperfusion (I/R) provokes lung injury via a mechanism that involves neutrophils [polymorphonuclear neutrophils (PMNs)]. CD11b/CD18 (alpha mB2) is the integrin receptor on PMNs critical for adhesion-dependent oxidative burst. The purpose of this study was to investigate the mechanistic role of CD11b in the process of gut I/R-induced lung injury. Sprague-Dawley rats underwent 45 minutes of superior mesenteric artery (SMA) occlusion with and without CD11b monoclonal antibody treatment (IB6) (1 mg/kg, i.v.), before SMA clamping. At 2-hour reperfusion, PMN presence in tissue was quantitated by myeloperoxidase activity and circulating PMN priming determined by the difference in superoxide production with and without N-formyl-methionyl-leucyl-phenylalanine, whereas lung leak was assessed by 125I-albumin lung/blood ratio. In sum, CD11b blockade prevented gut I/R-induced lung leak, but did not attenuate gut I/R-induced PMN priming or tissue PMN accumulation. In conclusion, gut I/R promotes PMN priming and PMN adhesion in both local and distant beds via receptors other than CD11b, but this B2 integrin receptor is critical for PMN-mediated endothelial injury.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636906     DOI: 10.1097/00005373-199507000-00003

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  11 in total

1.  Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury.

Authors:  Ming Zhang; William G Austen; Isaac Chiu; Elisabeth M Alicot; Rachel Hung; Minghe Ma; Nicola Verna; Min Xu; Herbert B Hechtman; Francis D Moore; Michael C Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

2.  Enteral nutrition prevents remote organ injury and death after a gut ischemic insult.

Authors:  K Fukatsu; B L Zarzaur; C D Johnson; A H Lundberg; H G Wilcox; K A Kudsk
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

3.  Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection.

Authors:  D J Wickel; W G Cheadle; M A Mercer-Jones; R N Garrison
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

Review 4.  Adaptive and maladaptive mechanisms of cellular priming.

Authors:  D R Meldrum; J C Cleveland; E E Moore; D A Partrick; A Banerjee; A H Harken
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

Review 5.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

6.  Group IIA phospholipase A2 mediates lung injury in intestinal ischemia-reperfusion.

Authors:  K Koike; Y Yamamoto; Y Hori; T Ono
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

7.  Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock.

Authors:  L J Magnotti; J S Upperman; D Z Xu; Q Lu; E A Deitch
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

8.  Postresuscitation tissue neutrophil infiltration is time-dependent and organ-specific.

Authors:  El Rasheid Zakaria; James E Campbell; James C Peyton; Richard N Garrison
Journal:  J Surg Res       Date:  2007-11       Impact factor: 2.192

9.  Leukotriene B4 receptor (BLT-1) modulates neutrophil influx into the peritoneum but not the lung and liver during surgically induced bacterial peritonitis in mice.

Authors:  Melanie J Scott; William G Cheadle; J Jason Hoth; James C Peyton; Krishnaprasad Subbarao; Wen-Hai Shao; Bodduluri Haribabu
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

10.  Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.

Authors:  Lavinia M Proctor; Thiruma V Arumugam; Ian Shiels; Robert C Reid; David P Fairlie; Stephen M Taylor
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.